Jonathan I. Lieber, Director at Salarius Pharmaceuticals, Inc. (SLRX), bought 37,500 shares at $0.19 ($7K) on 2022-06-07, disclosed to the SEC on 2022-06-08.
Open-market purchase of $7k SLRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| RLYB | BUY | 2023-03-16 | $26K | — | Filing → |
| HSGX | BUY | 2016-12-02 | $10K | — | Filing → |
| ALTU | SELL | 2007-12-18 | $18K | — | Filing → |